• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

链脲佐菌素诱导的糖尿病患者循环中微颗粒增加,促进炎症反应,导致微血管功能障碍。

Increased circulating microparticles in streptozotocin-induced diabetes propagate inflammation contributing to microvascular dysfunction.

机构信息

Department of Cellular and Molecular Physiology, College of Medicine, Penn State University, Hershey, PA, 17033, USA.

Department of Physiology and Pharmacology, School of Medicine, West Virginia University, Morgantown, WV, 26506, USA.

出版信息

J Physiol. 2019 Feb;597(3):781-798. doi: 10.1113/JP277312. Epub 2019 Jan 9.

DOI:10.1113/JP277312
PMID:30548258
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6355626/
Abstract

KEY POINTS

Circulating microparticles (MPs) are elevated in many cardiovascular diseases and have been considered as biomarkers of disease prognosis; however, current knowledge of MP functions has been mainly derived from in vitro studies and their precise impact on vascular inflammation and disease progression remains obscure. Using a diabetic rat model, we identified a >130-fold increase in MPs in plasma of diabetic rats compared to normal rats, the majority of which circulated as aggregates, expressing multiple cell markers and largely externalized phosphatidylserine; vascular images illustrate MP biogenesis and their manifestations in microvessels of diabetic rats. Using combined single microvessel perfusion and systemic cross-transfusion approaches, we delineated how diabetic MPs propagate inflammation in the vasculature and transform normal microvessels into an inflammatory phenotype observed in the microvessels of diabetic rats. Our observations derived from animal studies resembling conditions in diabetic patients, providing a mechanistic insight into MP-mediated pathogenesis of diabetes-associated multi-organ microvascular dysfunction.

ABSTRACT

In various cardiovascular diseases, microparticles (MPs), the membrane-derived vesicles released during cell activation, are markedly increased in the circulation. These MPs have been recognized to play diverse roles in the regulation of cellular functions. However, current knowledge of MP function has been largely derived from in vitro studies. The precise impact of disease-induced MPs on vascular inflammation and disease progression remains obscure. In this study we investigated the biogenesis, profile and functional roles of circulating MPs using a streptozotocin-induced diabetic rat model with well-characterized microvascular functions. Our study revealed a >130-fold increase in MPs in the plasma of diabetic rats compared to normal rats. The majority of these MPs originate from platelets, leukocytes and endothelial cells (ECs), and circulate as aggregates. Diabetic MPs show greater externalized phosphatidylserine (PS) than normal MPs. When diabetic plasma or isolated diabetic MPs were perfused into normal microvessels or systemically transfused into normal rats, MPs immediately adhered to endothelium and subsequently mediated leukocyte adhesion. These microvessels then exhibited augmented permeability responses to inflammatory mediators, replicating the microvascular manifestations observed in diabetic rats. These effects were abrogated when MPs were removed from diabetic plasma or when diabetic MPs were pre-coated with a lipid-binding protein, annexin V, suggesting externalized PS to be key in mediating MP interactions with endothelium and leukocytes. Our study demonstrated that the elevated MPs in diabetic plasma are actively involved in the propagation of vascular inflammation through their adhesive surfaces, providing mechanistic insight into the pathogenesis of multi-organ vascular dysfunction that commonly occurs in diabetic patients.

摘要

要点

循环微粒(MPs)在许多心血管疾病中升高,并被认为是疾病预后的生物标志物;然而,目前对 MPs 功能的认识主要来自体外研究,其对血管炎症和疾病进展的确切影响仍不清楚。使用糖尿病大鼠模型,我们发现与正常大鼠相比,糖尿病大鼠血浆中的 MPs 增加了>130 倍,其中大多数以聚集体的形式循环,表达多种细胞标志物,并大量外化磷脂酰丝氨酸;血管图像说明了 MPs 的发生和在糖尿病大鼠微血管中的表现。使用联合的单个微血管灌注和系统交叉输血方法,我们描述了糖尿病 MPs 如何在血管中传播炎症,并将正常微血管转化为糖尿病大鼠微血管中观察到的炎症表型。我们从类似于糖尿病患者的条件的动物研究中得出的观察结果,为 MPs 介导的糖尿病相关多器官微血管功能障碍的发病机制提供了机制上的见解。

摘要

在各种心血管疾病中,微粒(MPs),即在细胞激活过程中释放的膜衍生小泡,在循环中显著增加。这些 MPs 被认为在调节细胞功能方面发挥着多种作用。然而,目前对 MPs 功能的认识主要来自体外研究。疾病诱导的 MPs 对血管炎症和疾病进展的确切影响仍不清楚。在这项研究中,我们使用具有特征明确的微血管功能的链脲佐菌素诱导的糖尿病大鼠模型,研究了循环 MPs 的发生、特征和功能作用。我们的研究表明,与正常大鼠相比,糖尿病大鼠血浆中的 MPs 增加了>130 倍。这些 MPs 中的大多数来自血小板、白细胞和内皮细胞(EC),并以聚集体的形式循环。糖尿病 MPs 比正常 MPs 显示出更大的外化磷脂酰丝氨酸(PS)。当将糖尿病血浆或分离的糖尿病 MPs 灌注到正常微血管中或系统地输注到正常大鼠中时,MPs 立即粘附在内皮细胞上,随后介导白细胞粘附。这些微血管随后对炎症介质的通透性反应增强,复制了在糖尿病大鼠中观察到的微血管表现。当从糖尿病血浆中去除 MPs 或当用脂质结合蛋白, annexin V 预处理糖尿病 MPs 时,这些作用被阻断,表明外化 PS 是介导 MPs 与内皮细胞和白细胞相互作用的关键。我们的研究表明,糖尿病血浆中升高的 MPs 通过其粘附表面积极参与血管炎症的传播,为糖尿病患者常见的多器官血管功能障碍的发病机制提供了机制上的见解。

相似文献

1
Increased circulating microparticles in streptozotocin-induced diabetes propagate inflammation contributing to microvascular dysfunction.链脲佐菌素诱导的糖尿病患者循环中微颗粒增加,促进炎症反应,导致微血管功能障碍。
J Physiol. 2019 Feb;597(3):781-798. doi: 10.1113/JP277312. Epub 2019 Jan 9.
2
Microparticles are vectors of paradoxical information in vascular cells including the endothelium: role in health and diseases.微粒是包括内皮细胞在内的血管细胞中矛盾信息的载体:在健康和疾病中的作用。
Pharmacol Rep. 2008 Jan-Feb;60(1):75-84.
3
Circulating microparticles from diabetic rats impair endothelial function and regulate endothelial protein expression.循环微颗粒会损害糖尿病大鼠的内皮功能并调节内皮蛋白的表达。
Acta Physiol (Oxf). 2016 Feb;216(2):211-20. doi: 10.1111/apha.12561. Epub 2015 Aug 20.
4
Evolving role of microparticles in the pathophysiology of endothelial dysfunction.微粒在血管内皮功能障碍病理生理学中的作用演变。
Clin Chem. 2013 Aug;59(8):1166-74. doi: 10.1373/clinchem.2012.199711. Epub 2013 Mar 25.
5
Plasma microparticles of sickle patients during crisis or taking hydroxyurea modify endothelium inflammatory properties.镰状细胞病患者在危机期间或服用羟基脲时的血浆微粒会改变血管内皮的炎症特性。
Blood. 2020 Jul 9;136(2):247-256. doi: 10.1182/blood.2020004853.
6
ERK-containing microparticles from a diabetic mouse induce endothelial dysfunction.糖尿病小鼠 ERK 含微粒体诱导血管内皮功能障碍。
J Endocrinol. 2019 Jun 1;241(3):221-233. doi: 10.1530/JOE-18-0616.
7
Platelet Microparticles Mediate Glomerular Endothelial Injury in Early Diabetic Nephropathy.血小板微粒在早期糖尿病肾病中的肾小球内皮损伤中起介导作用。
J Am Soc Nephrol. 2018 Nov;29(11):2671-2695. doi: 10.1681/ASN.2018040368. Epub 2018 Oct 19.
8
Increased circulating microparticles contribute to severe infection and adverse outcomes of COVID-19 in patients with diabetes.循环中增加的微颗粒导致糖尿病患者 COVID-19 的严重感染和不良结局。
Am J Physiol Heart Circ Physiol. 2022 Dec 1;323(6):H1176-H1193. doi: 10.1152/ajpheart.00409.2022. Epub 2022 Oct 21.
9
Plasma microparticles in Alzheimer's disease: The role of vascular dysfunction.阿尔茨海默病中的血浆微粒:血管功能障碍的作用。
Metab Brain Dis. 2018 Feb;33(1):293-299. doi: 10.1007/s11011-017-0149-3. Epub 2017 Dec 5.
10
Microparticles: a component of various diseases.微粒:多种疾病的一个组成部分。
Pol Arch Med Wewn. 2012;122 Suppl 1:24-9.

引用本文的文献

1
Exosomes in Ocular Health: Recent Insights into Pathology, Diagnostic Applications and Therapeutic Functions.眼部健康中的外泌体:病理学、诊断应用及治疗功能的最新见解
Biomedicines. 2025 Jan 19;13(1):233. doi: 10.3390/biomedicines13010233.
2
Circulating small extracellular vesicles mediate vascular hyperpermeability in diabetes.循环中小细胞外囊泡介导糖尿病血管通透性增加。
Diabetologia. 2024 Jun;67(6):1138-1154. doi: 10.1007/s00125-024-06120-9. Epub 2024 Mar 15.
3
Emerging role of extracellular vesicles in diabetic retinopathy.细胞外囊泡在糖尿病视网膜病变中的新作用。
Theranostics. 2024 Feb 4;14(4):1631-1646. doi: 10.7150/thno.92463. eCollection 2024.
4
Regulation of exosome release by lysosomal acid ceramidase in coronary arterial endothelial cells: Role of TRPML1 channel.溶酶体酸性神经酰胺酶调控冠状动脉内皮细胞外泌体的释放:TRPML1 通道的作用。
Curr Top Membr. 2022;90:37-63. doi: 10.1016/bs.ctm.2022.09.002. Epub 2022 Oct 3.
5
Increased circulating microparticles contribute to severe infection and adverse outcomes of COVID-19 in patients with diabetes.循环中增加的微颗粒导致糖尿病患者 COVID-19 的严重感染和不良结局。
Am J Physiol Heart Circ Physiol. 2022 Dec 1;323(6):H1176-H1193. doi: 10.1152/ajpheart.00409.2022. Epub 2022 Oct 21.
6
Size Distribution of Microparticles: A New Parameter to Predict Acute Lung Injury After Cardiac Surgery With Cardiopulmonary Bypass.微粒的大小分布:预测体外循环心脏手术后急性肺损伤的一个新参数。
Front Cardiovasc Med. 2022 Apr 29;9:893609. doi: 10.3389/fcvm.2022.893609. eCollection 2022.
7
Endoplasmic Reticulum (ER) Stress-Generated Extracellular Vesicles (Microparticles) Self-Perpetuate ER Stress and Mediate Endothelial Cell Dysfunction Independently of Cell Survival.内质网(ER)应激产生的细胞外囊泡(微粒)可使内质网应激自我延续,并独立于细胞存活介导内皮细胞功能障碍。
Front Cardiovasc Med. 2020 Dec 10;7:584791. doi: 10.3389/fcvm.2020.584791. eCollection 2020.
8
Interplay between Endoplasmic Reticulum Stress and Large Extracellular Vesicles (Microparticles) in Endothelial Cell Dysfunction.内质网应激与大细胞外囊泡(微粒)在内皮细胞功能障碍中的相互作用
Biomedicines. 2020 Oct 12;8(10):409. doi: 10.3390/biomedicines8100409.

本文引用的文献

1
Ursolic acid improves diabetic nephropathy via suppression of oxidative stress and inflammation in streptozotocin-induced rats.熊果酸通过抑制链脲佐菌素诱导的大鼠氧化应激和炎症改善糖尿病肾病。
Biomed Pharmacother. 2018 Sep;105:915-921. doi: 10.1016/j.biopha.2018.06.055. Epub 2018 Jun 19.
2
Simvastatin ameliorates diabetic nephropathy by attenuating oxidative stress and apoptosis in a rat model of streptozotocin-induced type 1 diabetes.辛伐他汀通过减轻链脲佐菌素诱导的 1 型糖尿病大鼠模型中的氧化应激和细胞凋亡来改善糖尿病肾病。
Biomed Pharmacother. 2018 Sep;105:290-298. doi: 10.1016/j.biopha.2018.05.130. Epub 2018 Jun 1.
3
Protection from vascular dysfunction in female rats with chronic stress and depressive symptoms.慢性应激和抑郁症状的雌性大鼠血管功能障碍的保护。
Am J Physiol Heart Circ Physiol. 2018 May 1;314(5):H1070-H1084. doi: 10.1152/ajpheart.00647.2017. Epub 2018 Feb 16.
4
Protection from chronic stress- and depressive symptom-induced vascular endothelial dysfunction in female rats is abolished by preexisting metabolic disease.慢性应激和抑郁症状引起的血管内皮功能障碍在患有代谢疾病的雌性大鼠中无法被保护。
Am J Physiol Heart Circ Physiol. 2018 May 1;314(5):H1085-H1097. doi: 10.1152/ajpheart.00648.2017. Epub 2018 Feb 16.
5
Microvesicles in Atherosclerosis and Angiogenesis: From Bench to Bedside and Reverse.动脉粥样硬化与血管生成中的微泡:从实验台到临床应用及逆向转化
Front Cardiovasc Med. 2017 Dec 18;4:77. doi: 10.3389/fcvm.2017.00077. eCollection 2017.
6
Plasma microparticles in Alzheimer's disease: The role of vascular dysfunction.阿尔茨海默病中的血浆微粒:血管功能障碍的作用。
Metab Brain Dis. 2018 Feb;33(1):293-299. doi: 10.1007/s11011-017-0149-3. Epub 2017 Dec 5.
7
Circulating microparticles in acute diabetic Charcot foot exhibit a high content of inflammatory cytokines, and support monocyte-to-osteoclast cell induction.在急性糖尿病夏科氏足中循环的微颗粒表现出高含量的炎症细胞因子,并支持单核细胞向破骨细胞的诱导。
Sci Rep. 2017 Nov 27;7(1):16450. doi: 10.1038/s41598-017-16365-7.
8
Insights into the Diagnostic Potential of Extracellular Vesicles and Their miRNA Signature from Liquid Biopsy as Early Biomarkers of Diabetic Micro/Macrovascular Complications.从液体活检中探索细胞外囊泡及其 miRNA 特征作为糖尿病微/大血管并发症的早期生物标志物的诊断潜力。
Int J Mol Sci. 2017 Sep 14;18(9):1974. doi: 10.3390/ijms18091974.
9
High glucose increases the formation and pro-oxidative activity of endothelial microparticles.高血糖会增加内皮细胞微颗粒的形成和促氧化活性。
Diabetologia. 2017 Sep;60(9):1791-1800. doi: 10.1007/s00125-017-4331-2. Epub 2017 Jun 10.
10
Microvesicles in vascular homeostasis and diseases. Position Paper of the European Society of Cardiology (ESC) Working Group on Atherosclerosis and Vascular Biology.血管稳态和疾病中的微囊泡。欧洲心脏病学会(ESC)动脉粥样硬化和血管生物学工作组立场文件。
Thromb Haemost. 2017 Jun 28;117(7):1296-1316. doi: 10.1160/TH16-12-0943. Epub 2017 Jun 1.